Rice University Receives $45 Million Funding for Revolutionary Cancer Treatment
Scientists at Rice University have been awarded a staggering $45 million in funding from the Advanced Research Projects Agency for Health. The grant will be used to develop a groundbreaking implant-based treatment system that has the potential to cure cancer.
Known as the “sense-and-respond implant technology,” this state-of-the-art system aims to improve the outcomes of immunotherapy treatment. By delivering immunotherapy drugs directly to patients through a closed-loop system, the researchers hope to revolutionize the way cancer is treated.
The implant, named the “hybrid advanced molecular manufacturing regulator” (HAMMR), has the potential to completely eradicate cancer in as few as two months. The team of experts behind this project, known as THOR, believes that the implant will only be required for short-term use.
What sets this implant apart from other medical devices is its ability to provide real-time data from the tumor environment. This data will help guide medical professionals in developing more effective and targeted therapies for patients, leading to improved treatment outcomes.
Comprised of researchers and experts from 20 labs across the country, the THOR project aims to revolutionize cancer treatment. The first clinical trial will focus on studying the implant’s effectiveness in treating recurrent ovarian cancer. Human trials are expected to commence within the next five years.
Last year, the research team successfully demonstrated the effectiveness of their “drug factory” technology in mice. In just six days, late-stage ovarian and colorectal cancers in the animals were eradicated. The new implant represents the next iteration of this groundbreaking approach.
The funding from the Advanced Research Projects Agency for Health will provide the necessary resources for further research and development. The groundbreaking technology developed by Rice University’s scientists offers hope to millions of cancer patients worldwide. By improving the efficacy and speed of treatment, the sense-and-respond implant technology has the potential to revolutionize cancer care as we know it.